Literature DB >> 15886531

Stroke in patients with diabetes and hypertension.

Samy I McFarlane1, Domenic A Sica, James R Sowers.   

Abstract

Stroke is major public health problem leading to increased morbidity and mortality. Modifiable risk factors for stroke include hypertension, diabetes, atrial fibrillation, dyslipidemia, smoking, and alcohol abuse. Among these risk factors, diabetes and hypertension are rapidly growing epidemics leading to a substantial increase in cardiovascular disease and stroke. In this review, the authors discuss the risk factors for stroke with emphasis on the diabetic and hypertensive population, highlighting the interventions that have been shown to decrease stroke risk in this patient population.

Entities:  

Mesh:

Year:  2005        PMID: 15886531      PMCID: PMC8109587          DOI: 10.1111/j.1524-6175.2005.04379.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  63 in total

Review 1.  Diabetes and glucose intolerance as risk factors for stroke.

Authors:  J Tuomilehto; D Rastenyte
Journal:  J Cardiovasc Risk       Date:  1999-08

2.  Diabetes mellitus: a risk factor for carotid endarterectomy?

Authors:  C M Akbari; F B Pomposelli; G W Gibbons; D R Campbell; D V Freeman; F W LoGerfo
Journal:  J Vasc Surg       Date:  1997-06       Impact factor: 4.268

Review 3.  Reducing the risk of stroke in diabetes: what have we learned that is new?

Authors:  Ralph L Sacco
Journal:  Diabetes Obes Metab       Date:  2002-01       Impact factor: 6.577

4.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

Review 5.  New evidence for stroke prevention: scientific review.

Authors:  Sharon E Straus; Sumit R Majumdar; Finlay A McAlister
Journal:  JAMA       Date:  2002-09-18       Impact factor: 56.272

6.  The association of hyperglycemia with cerebral edema in stroke.

Authors:  L Berger; A M Hakim
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

Review 7.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

8.  Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks.

Authors:  M C Riddle; J Hart
Journal:  Stroke       Date:  1982 May-Jun       Impact factor: 7.914

Review 9.  Atrial fibrillation, anticoagulation, and stroke.

Authors:  J Morley; R Marinchak; S J Rials; P Kowey
Journal:  Am J Cardiol       Date:  1996-01-25       Impact factor: 2.778

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more
  9 in total

1.  Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic.

Authors:  Navneet Sharma; Justin Lee; Irini Youssef; Moro O Salifu; Samy I McFarlane
Journal:  J Sleep Disord Ther       Date:  2017-03-10

Review 2.  Blood pressure and cardiovascular effects of new and emerging antidiabetic agents.

Authors:  Pelbreton C Balfour; Carlos J Rodriguez; Keith C Ferdinand
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

3.  Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians.

Authors:  Laurentia Mihardja; Uken Soetrisno; Sidartawan Soegondo
Journal:  J Diabetes Investig       Date:  2013-12-01       Impact factor: 4.232

4.  Arterial hypertension in diabetes mellitus: from theory to clinical practice.

Authors:  C Sampanis; C Zamboulis
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

Review 5.  Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.

Authors:  Francesco De Sensi; Tom De Potter; Alberto Cresti; Silva Severi; Günter Breithardt
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

6.  Hypertension in the high-cardiovascular-risk populations.

Authors:  Samy I McFarlane; Girardin Jean-Louis; Ferdinand Zizi; Adam T Whaley-Connell; Olugbenga Ogedegbe; Amgad N Makaryus; Ilir Maraj
Journal:  Int J Hypertens       Date:  2012-06-21       Impact factor: 2.420

7.  Identifying treatment related problems and associated factors among hospitalized post-stroke patients through medication management review: A multi-center study.

Authors:  Iman A Basheti; Shahnaz Mohammed Ayasrah; Muayyad Ahmad
Journal:  Saudi Pharm J       Date:  2018-10-19       Impact factor: 4.330

Review 8.  Group visits in the management of diabetes and hypertension: effect on glycemic and blood pressure control.

Authors:  Lisel M Loney-Hutchinson; Alfrede D Provilus; Girardin Jean-Louis; Ferdinand Zizi; Olugbenga Ogedegbe; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 5.430

9.  Moderating effects of sleep duration on diabetes risk among cancer survivors: analysis of the National Health Interview Survey in the USA.

Authors:  Azizi A Seixas; Lloyd Gyamfi; Valerie Newsome; Gabrielle Ranger-Murdock; Mark Butler; Diana Margot Rosenthal; Ferdinand Zizi; Irini Youssef; Samy I McFarlane; Girardin Jean-Louis
Journal:  Cancer Manag Res       Date:  2018-10-12       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.